• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙调磷酸酶抑制剂他克莫司抑制宿主对尿路感染的免疫应答。

Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection.

机构信息

Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Renal Transplant Unit, Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Sci Rep. 2019 Jan 14;9(1):106. doi: 10.1038/s41598-018-37482-x.

DOI:10.1038/s41598-018-37482-x
PMID:30643171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6331640/
Abstract

Calcineurin inhibitor Tacrolimus, is a potent immunosuppressive drug widely used in order to prevent acute graft rejection. Urinary tract infection (UTI) is the most frequent infectious complication in renal transplant patients and long-term use of Tacrolimus might be involved in higher susceptibility to bacterial infections. It remains largely unknown how Tacrolimus affects the host innate immune response against lower and upper UTI. To address this issue, we used experimental UTI model by intravesical inoculation of uropathogenic E.coli in female wild-type mice pre-treated with Tacrolimus or solvent (CTR). We found that Tacrolimus pre-treated mice displayed higher bacterial loads (cystitis, pyelonephritis and bacteremia) than CTR mice. Granulocytes from Tacrolimus pre-treated mice phagocytized less E. coli, released less MPO and expressed decreased levels of CXCR2 receptor upon infection. Moreover, Tacrolimus reduced TLR5 expression in bladder macrophages during UTI. This immunosuppressive state can be explained by the upregulation of TLR-signaling negative regulators (A20, ATF3, IRAK-M and SOCS1) and parallel downregulation of TLR5 as observed in Tacrolimus treated granulocytes and macrophages. We conclude that Tacrolimus impairs host innate immune responses against UTI.

摘要

钙调磷酸酶抑制剂他克莫司是一种强效免疫抑制剂,广泛用于预防急性移植物排斥反应。尿路感染(UTI)是肾移植患者最常见的感染性并发症,而长期使用他克莫司可能与更高的细菌感染易感性有关。他克莫司如何影响宿主对下尿路感染和上尿路感染的固有免疫反应,在很大程度上仍不清楚。为了解决这个问题,我们使用了经膀胱接种尿路致病性大肠杆菌的实验性尿路感染模型,在该模型中,雌性野生型小鼠预先用他克莫司或溶剂(CTR)处理。我们发现,与 CTR 小鼠相比,预先用他克莫司处理的小鼠显示出更高的细菌负荷(膀胱炎、肾盂肾炎和菌血症)。感染时,预先用他克莫司处理的小鼠中性粒细胞吞噬的大肠杆菌减少,释放的髓过氧化物酶减少,表达的 CXCR2 受体水平降低。此外,在尿路感染期间,他克莫司下调了膀胱巨噬细胞中的 TLR5 表达。这种免疫抑制状态可以通过 TLR 信号负调节因子(A20、ATF3、IRAK-M 和 SOCS1)的上调以及在他克莫司处理的粒细胞和巨噬细胞中观察到的 TLR5 的平行下调来解释。我们得出结论,他克莫司损害了宿主对尿路感染的固有免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/29aef84b649e/41598_2018_37482_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/0d310f0fd37b/41598_2018_37482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/72ca5886f14a/41598_2018_37482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/2241fa880ba3/41598_2018_37482_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/f18fcdbb6943/41598_2018_37482_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/c0d40af218e1/41598_2018_37482_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/db432b858ff8/41598_2018_37482_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/189470f9a0bb/41598_2018_37482_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/29aef84b649e/41598_2018_37482_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/0d310f0fd37b/41598_2018_37482_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/72ca5886f14a/41598_2018_37482_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/2241fa880ba3/41598_2018_37482_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/f18fcdbb6943/41598_2018_37482_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/c0d40af218e1/41598_2018_37482_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/db432b858ff8/41598_2018_37482_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/189470f9a0bb/41598_2018_37482_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee1a/6331640/29aef84b649e/41598_2018_37482_Fig8_HTML.jpg

相似文献

1
Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection.钙调磷酸酶抑制剂他克莫司抑制宿主对尿路感染的免疫应答。
Sci Rep. 2019 Jan 14;9(1):106. doi: 10.1038/s41598-018-37482-x.
2
Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.尿路致病性大肠杆菌的毒力与尿路感染过程中的固有免疫应答。
Curr Opin Microbiol. 2013 Feb;16(1):100-7. doi: 10.1016/j.mib.2013.01.005. Epub 2013 Feb 8.
3
Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.荠麦种子粗多糖通过刺激肾脏固有免疫预防尿路感染。
J Ethnopharmacol. 2020 Oct 5;260:112578. doi: 10.1016/j.jep.2020.112578. Epub 2020 Jan 18.
4
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.尿路致病性大肠杆菌在巨噬细胞内的存活:不同临床分离株之间以及小鼠和人巨噬细胞之间的差异。
Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.
5
Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.快速膀胱白细胞介素-10 的合成是对尿路致病性大肠杆菌的反应的一部分,是由主要细菌鞭毛丝状蛋白 FliC 触发的防御策略的一部分,并且依赖于 TLR5。
mSphere. 2019 Nov 27;4(6):e00545-19. doi: 10.1128/mSphere.00545-19.
6
Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.在实验性大肠杆菌膀胱炎中,杀菌肽增强上皮细胞的易感性和发病机制。
J Infect Dis. 2015 Apr 1;211(7):1164-73. doi: 10.1093/infdis/jiu577. Epub 2014 Oct 21.
7
Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo.Atg16L1 缺陷赋予体内抵抗泌尿道致病性大肠杆菌感染的保护作用。
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):11008-13. doi: 10.1073/pnas.1203952109. Epub 2012 Jun 19.
8
Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic During Urinary Tract Infections.鼠源 SIGNR1(CD209b)有助于清除尿路致病性 期间尿路感染。
Front Cell Infect Microbiol. 2020 Jan 10;9:457. doi: 10.3389/fcimb.2019.00457. eCollection 2019.
9
Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.糖尿病小鼠对尿路感染的细胞因子表达受损、中性粒细胞浸润及细菌清除功能受损。
Pathog Dis. 2015 Apr;73(3). doi: 10.1093/femspd/ftv002. Epub 2015 Feb 5.
10
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli.免疫抑制治疗会改变回肠抗菌肽的分泌和肠道微生物群,并有利于随后尿路致病性大肠杆菌的定殖。
Transplantation. 2017 Jan;101(1):74-82. doi: 10.1097/TP.0000000000001492.

引用本文的文献

1
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.抑制钙调神经磷酸酶可能预防唐氏综合征患者患阿尔茨海默病。
Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.
2
Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients.他克莫司和霉酚酸介导的毒性:移植后患者管理中的临床考量与选择
Curr Issues Mol Biol. 2024 Dec 24;47(1):2. doi: 10.3390/cimb47010002.
3
Efficacy and safety of calcineurin inhibitors (CNIs) for septic patients in ICU: a cohort study from MIMIC database.

本文引用的文献

1
Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury.肠道微生物群的消耗可预防肾缺血再灌注损伤。
J Am Soc Nephrol. 2017 May;28(5):1450-1461. doi: 10.1681/ASN.2016030255. Epub 2016 Dec 7.
2
Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.钙调神经磷酸酶抑制剂环孢素 A 和他克莫司通过 TLR4 信号诱导血管炎症和内皮细胞活化。
Sci Rep. 2016 Jun 13;6:27915. doi: 10.1038/srep27915.
3
A simple practice guide for dose conversion between animals and human.
重症监护病房中脓毒症患者使用钙调神经磷酸酶抑制剂(CNIs)的疗效与安全性:一项来自MIMIC数据库的队列研究
Front Pharmacol. 2024 Sep 18;15:1394553. doi: 10.3389/fphar.2024.1394553. eCollection 2024.
4
The Role of the Urobiome in Kidney Transplantation: A Systematic Review.尿微生物群在肾移植中的作用:一项系统评价
Transplant Direct. 2024 May 17;10(6):e1643. doi: 10.1097/TXD.0000000000001643. eCollection 2024 Jun.
5
Falsely Elevated Tacrolimus (FK506) Trough Levels in a Liver Transplant Recipient.肝移植受者中环孢素A(FK506)谷浓度假性升高
Cureus. 2024 Feb 20;16(2):e54548. doi: 10.7759/cureus.54548. eCollection 2024 Feb.
6
Tacrolimus Pharmacotherapy: Infectious Complications and Toxicity in Organ Transplant Recipients; An Updated Review.他克莫司药物治疗:器官移植受者的感染并发症与毒性;最新综述
Curr Drug Res Rev. 2025;17(2):301-310. doi: 10.2174/0125899775259326231212073240.
7
Multiple Shades of Gray-Macrophages in Acute Allograft Rejection.急性移植排斥反应中的多种灰色-巨噬细胞。
Int J Mol Sci. 2023 May 4;24(9):8257. doi: 10.3390/ijms24098257.
8
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression.用 AAV 载体减轻基因治疗中的严重不良事件:载体剂量和免疫抑制。
Drugs. 2023 Mar;83(4):287-298. doi: 10.1007/s40265-023-01836-1. Epub 2023 Jan 30.
9
Bacterial Urinary Tract Infection and Early Asymptomatic Bacteriuria in Kidney Transplantation Still Negatively Affect Kidney Transplant Outcomes in the Era of Modern Immunosuppression and Cotrimoxazole Prophylaxis.在现代免疫抑制和复方新诺明预防的时代,肾移植中的细菌性尿路感染和早期无症状菌尿症仍然对肾移植结果产生负面影响。
Biomedicines. 2022 Nov 20;10(11):2984. doi: 10.3390/biomedicines10112984.
10
Pediatric kidney transplant recipients with and without underlying structural kidney disease have a comparable risk of hospitalization associated with urinary tract infections.患有和未患有潜在结构性肾病的小儿肾移植受者因尿路感染而住院的风险相当。
Front Pediatr. 2022 Sep 2;10:953139. doi: 10.3389/fped.2022.953139. eCollection 2022.
动物与人之间剂量转换的简易实践指南。
J Basic Clin Pharm. 2016 Mar;7(2):27-31. doi: 10.4103/0976-0105.177703.
4
The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.甲氧苄啶-磺胺甲恶唑作为耶氏肺孢子菌肺炎预防用药对肾移植受者无症状菌尿症和尿路感染发生率的影响:一项前后对照的回顾性研究。
BMC Infect Dis. 2016 Feb 25;16:90. doi: 10.1186/s12879-016-1432-3.
5
The lectin like domain of thrombomodulin is involved in the defence against pyelonephritis.血栓调节蛋白的凝集素样结构域参与了对肾盂肾炎的防御。
Thromb Res. 2015 Dec;136(6):1325-31. doi: 10.1016/j.thromres.2015.11.004. Epub 2015 Nov 10.
6
Macrophages Subvert Adaptive Immunity to Urinary Tract Infection.巨噬细胞破坏对尿路感染的适应性免疫。
PLoS Pathog. 2015 Jul 16;11(7):e1005044. doi: 10.1371/journal.ppat.1005044. eCollection 2015 Jul.
7
Toll-like receptors.Toll样受体
Curr Protoc Immunol. 2015 Apr 1;109:14.12.1-14.12.10. doi: 10.1002/0471142735.im1412s109.
8
Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus.吞噬作用依赖的TLR9-BTK-钙调神经磷酸酶-NFAT途径激活协调对烟曲霉的固有免疫。
EMBO Mol Med. 2015 Mar;7(3):240-58. doi: 10.15252/emmm.201404556.
9
Pattern recognition receptors and the inflammasome in kidney disease.模式识别受体和炎症小体在肾脏疾病中的作用。
Nat Rev Nephrol. 2014 Jul;10(7):398-414. doi: 10.1038/nrneph.2014.91. Epub 2014 Jun 3.
10
Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.哨兵细胞和辅助型巨噬细胞之间的串扰允许中性粒细胞迁移到受感染的尿路上皮中。
Cell. 2014 Jan 30;156(3):456-68. doi: 10.1016/j.cell.2014.01.006.